India, April 16 -- While reporting financial results for the first quarter on Wednesday, Abbott Laboratories (ABT) provided adjusted earnings guidance for the second quarter and reaffirmed its outlook for the full-year 2025.
For the second quarter, Abbott projects adjusted earnings in a range of $1.23 to $1.27 per share. On average, 19 analysts polled expect the company to report earnings of $1.25 per share for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to fiscal 2025, the company continues to project adjusted earnings in the range of $5.05 to $5.25 per share on organic sales growth of 7.5 to 8.5 percent.
The Street is looking for earnings of $5.15 per share on revenue growth of 5.87 percent to $44.41...